Study: NCT00963768

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ 28431754
Description: A liquid suspension of 30 mg, 100 mg, 300 mg of JNJ-28431754 taken once (or twice) daily or 600 mg taken once daily will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ 28431754
Description: A liquid suspension of 30 mg, 100 mg, 300 mg of JNJ-28431754 taken once (or twice) daily or 600 mg taken once daily will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ 28431754
Description: A liquid suspension of 30 mg, 100 mg, 300 mg of JNJ-28431754 taken once (or twice) daily or 600 mg taken once daily will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ 28431754
Description: A liquid suspension of 30 mg, 100 mg, 300 mg of JNJ-28431754 taken once (or twice) daily or 600 mg taken once daily will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ 28431754
Description: A liquid suspension of 30 mg, 100 mg, 300 mg of JNJ-28431754 taken once (or twice) daily or 600 mg taken once daily will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A liquid suspension of placebo will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser once or twice daily for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A liquid suspension of placebo will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser once or twice daily for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A liquid suspension of placebo will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser once or twice daily for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A liquid suspension of placebo will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser once or twice daily for 14 days (Day 1 and Days 3 through 16).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A liquid suspension of placebo will be administered by study personnel directly into the patient's mouth using an oral liquid dispenser once or twice daily for 14 days (Day 1 and Days 3 through 16).